Evidence map›Paper›PMID 22969158›Full record

ArticleScience signaling2012

Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Daisuke Hoshino, Jerome Jourquin, Shane Weller Emmons, Tyne Miller, Margalit Goldgof, Kaitlin Costello, Darren R Tyson, Brandee Brown, Yiling Lu, Nagendra K Prasad and 6 more

Abstract read
In one paragraph

Article in Science signaling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  10. Article
  11. PTEN and Other PtdIns(3,4,5)PInternational journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Daisuke HoshinoDivision of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Jerome Jourquin
Shane Weller Emmons
Tyne Miller
Margalit Goldgof
Kaitlin Costello
Darren R Tyson
Brandee Brown
Yiling Lu
Nagendra K Prasad
Bing Zhang
Gordon B Mills
Wendell G Yarbrough
Vito Quaranta
Motoharu Seiki
Alissa M Weaver
Vanderbilt University · USThe University of Tokyo · JP

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Targeting the PI3K Signaling Pathway in Endometrial CarcinomaP50CA098258 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BODURKA, DIANE · 2003 to 2020
$32.0M
Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GRAY, JOE W. · 2004 to 2014
$27.1M
Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MYERS, JEFFREY NICHOLAS · 2002 to 2012
$26.1M
TrainingU54CA113007 · NCI · VANDERBILT UNIVERSITY · PI ESTRADA-RODGERS, LOURDES · 2004 to 2014
$19.2M
Systems Approach to the Biological Basis of Colon Cancer MetastasesR01GM088822 · NIGMS · VANDERBILT UNIVERSITY · PI BEAUCHAMP, ROBERT DANIEL, ZHANG, BING · 2009 to 2012
$1.5M
Cortactin function in lamellipodial protrusionR01GM075126 · NIGMS · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2007 to 2011
$1.4M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA097007NCI NIH HHS P50CA097007NCI NIH HHS U54 CA112970NCI NIH HHS U54 CA113007NCI NIH HHS U54CA113007NIGMS NIH HHS R01 GM075126NIGMS NIH HHS R01 GM088822
6 · The paper itself

Abstract

In cancer, deregulated signaling can produce an invasive cellular phenotype. We modeled the invasive transition as a theoretical switch between two cytoskeletal structures: focal adhesions and extracellular matrix-degrading invadopodia. We constructed molecular interaction networks of each structure and identified upstream regulatory hubs through computational analyses. We compared these regulatory hubs to the status of signaling components from head and neck carcinomas, which led us to analyze phosphatidylinositol 3-kinase (PI3K) and protein kinase C α (PKCα). Consistent with previous studies, PI3K activity promoted both the formation and the activity of invadopodia. We found that PI3K induction of invadopodia was increased by overexpression of SH2 (Src homology 2) domain-containing inositol 5'-phosphatase 2 (SHIP2), which converts the phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P(3)] that is produced by PI3K activity to phosphatidylinositol 3,4-bisphosphate [PI(3,4)P(2)], which is believed to promote invadopodia formation. Knockdown of PKCα had divergent effects on invadopodia formation, depending on the status of PI3K. Loss of PKCα inhibited invadopodia formation in cells with wild-type PI3K pathway status. Conversely, in cells with constitutively active PI3K (through activating PI3K mutants or lacking the endogenous opposing enzyme PTEN), PKCα knockdown increased invadopodia formation. Mechanistic studies revealed a negative feedback loop from PKCα that dampened PI3K activity and invasive behavior in cells with genetic hyperactivation of the PI3K pathway. These studies demonstrated the potential of network modeling as a discovery tool and identified PI3K and PKCα as interacting regulators of invasive behavior.

Indexed as

Models, BiologicalCell Line, TumorFocal AdhesionsGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansNeoplasm InvasivenessNeoplasm ProteinsPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesPhosphoric Monoester HydrolasesProtein Kinase C-alphaSignal TransductionINPPL1 protein, humanNeoplasm ProteinsPhosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatasesphosphatidylinositol 3,4-diphosphatePhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesPhosphoric Monoester HydrolasesPRKCA protein, humanProtein Kinase C-alpha

Identifiers

PMID22969158
PMCPMC3583194
OpenAlexW2117945647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.